show episodes
 
N
NEI Podcast

1
NEI Podcast

Neuroscience Education Institute

Unsubscribe
Unsubscribe
Monthly+
 
The Neuroscience Education Institute (NEI) is committed to help raise the standard of mental health by providing imaginative medical education that focuses on the highest level of learning. Each episode offers an opportunity to learn about current issues in psychiatry from key opinion leaders in the medical field. NEI's Podcast would be of value to anyone with an interest in neuropsychiatric diseases and psychopharmacology.
 
Loading …
show series
 
Why are you so passionate about mental health care in the primary care setting? When did you first experience your own challenges with mental health? What is your advice for mental health professionals and medical professionals when it comes to prioritizing their own mental health? In this episode, Dr. Linda Gask answers these questions and much mo…
 
In this episode, Dr. Andrew Cutler interviews Dr. Stephen Stahl on creativity in bipolar disorder. With this special series, brought to you by the NEI Podcast we will address a different theme in psychopharmacology every 3 months. Each theme is split into 3 parts, with one part released each month. This theme is on practical psychopharmacology. Epi…
 
What led you to pursue a career in auditory neuroscience and what is the mission behind your laboratory, Brainvolts? What is the effect of bilingualism on Alzheimer’s disease? How can sound be used for the assessment of traumatic brain injury and other neurological conditions? In this episode, Dr. Nina Kraus addresses these questions and much more …
 
In this episode, Dr. Andrew Cutler interviews Dr. Rajnish Mago on best practices for early detection and screening for tardive dyskinesia. Optional CME/CE Credits and Certificate Instructions: After listening to the podcast, to take the optional posttest and receive CME/CE credit, click: https://nei.global/POD22-TD01 Learning Objectives: After comp…
 
In what ways do we have the power to influence neuroplasticity? How would you define pathologic or dark neuroplasticity? Are there ways to enhance or preserve our circuits as a form of adaptive neuroplasticity? In this episode, Dr. Andrew Cutler interviews Dr. Stephen Stahl on dark neuroplasticity. With this special series, brought to you by the NE…
 
What was your personal experience with Match Day? What has your personal experience been like being transgender and how has this impacted your professional track when it comes to clinicians treating patients who are nonbinary or transgender? In this podcast episode, Dr. Mulkey addresses these questions and more about psychiatry residency and Match …
 
Which unique factors of social media place it in a powerful position to influence people? How is marketing used as mass persuasion? In this episode, Dr. Andrew Cutler interviews Dr. Donatella Marazziti on dark persuasion and social media. With this special series, brought to you by the NEI Podcast we will address a different theme in psychopharmaco…
 
What was your experience like as co-chair of the Revision Subcommittee and DSM-5-TR editor? How was the impact of racism and discrimination on the diagnosis and manifestations of mental disorders addressed? In this important and timely episode, Dr. Michael First addresses these questions and much more about the upcoming release of the DSM-5-TR in M…
 
In this episode, Dr. Andrew Cutler interviews Dr. Stephen Stahl on best practices for switching antipsychotics. Optional CME/CE Credits and Certificate Instructions: After listening to the podcast, to take the optional posttest and receive CME/CE credit, click: https://nei.global/POD22-Switch Learning Objectives: After completing this educational a…
 
How did you come about writing “Dark Persuasion”? What exactly is brainwashing? What are the common features of torture and coercive persuasion? In this episode, Dr. Andrew Cutler interviews Dr. Joel Dimsdale about his new book, “Dark Persuasion”. With this special series, brought to you by the NEI Podcast we will address a different theme in psych…
 
What exactly is seasonal affective disorder (SAD)? What are some of the most common symptoms? In this episode, Dr. Jade Wu addresses these questions and much more about SAD. Jade Wu, PhD, DBSM, is a Board-certified behavioral sleep medicine specialist and researcher at Duke University School of Medicine. Her current research focuses on treating sle…
 
In this episode, Dr. Andrew Cutler interviews Dr. Joseph Goldberg on the management of metabolic side effects associated with antipsychotics. Optional CME/CE Credits and Certificate Instructions: After listening to the podcast, to take the optional posttest and receive CME/CE credit, click https://nei.global/POD21-MET Learning Objectives: After com…
 
Can you explain how the same symptoms may cut across numerous psychiatric disorders and how the same treatment may be efficacious across psychiatric disorders? What areas in psychopharmacology remain the most challenging to treat and why do you think that is? In this episode, Dr. Andrew Cutler interviews Dr. Stephen Stahl about the future of psycho…
 
Who is Pear and what are prescription digital therapeutics? Why are PDTs so important to the continuum of care, especially when it comes to mental health? In this fascinating interview, Dr. Andrew Cutler interviews Dr. Corey McMann, the President and CEO of Pear Therapeutics about the importance of this technology in treating mental health. Corey M…
 
What are some of the new FDA approvals for medications that happened this year? What did we learn about the association between ADHD and Alzheimer’s disease from a nationwide cohort study that was conducted? In this important and timely episode, Dr. Andrew Cutler addresses these questions and many more on the most interesting updates in psychopharm…
 
What was the inspiration behind creating the Fifth Edition video series? What are your best learning strategies for studying psychopharmacology? In this episode, Dr. Andrew Cutler interviews Dr. Stephen Stahl about the Fifth Edition Video Series and about the most effective learning strategies for psychopharmacology! With this special series, broug…
 
In this episode, Dr. Jeffrey Strawn addresses your unanswered questions from his presentation: Re-Counting Neurobiological Treatment Advances of Obsessive-Compulsive Disorder. Dr. Jeffrey R. Strawn's early work examined the neurophysiology, neurochemistry and neuroanatomy of anxiety disorders in children and adolescents.In parallel with Dr. Strawn'…
 
In this episode, Dr. Manpreet Singh answers your unaddressed questions from her presentation: It's a Woman's World: Exploring Female Mental Health Issues at the 2021 NEI Congress. Dr. Manpreet K. Singh is Associate Professor of Psychiatry and Behavioral Sciences, and leads a program aimed to accelerate understanding and treatment in youth with or a…
 
In this episode, Dr. Napoleon Higgins and Dr. Rona Hu address your most pressing questions from their presentation on cultural humility at the 2021 NEI Congress. Dr. Napoleon Higgins is a child, adolescent and adult psychiatrist in Houston, Texas. He is the owner of Bay Pointe Behavioral Health Services and South East Houston Research Group. He is …
 
In this episode, Dr. Charles Scott addresses some of your unanswered questions from his presentation on cannabis and violence. Dr. Scott is Chief, Division of Psychiatry and the Law, Forensic Psychiatry Fellowship Training Director, and Professor of Clinical Psychiatry at the University of California, Davis Medical Center in Sacramento, California.…
 
What are you most excited about, when it comes to this year’s NEI Congress? What is one benefit that both live and virtual attendees will experience at the 2021 NEI Congress? In this episode, we get a sneak peek at what to expect from this highly anticipated event! With the live and virtual simulcast formats, there are a lot of questions and A LOT …
 
In this episode, Dr. Andrew Cutler interviews Dr. Roger McIntyre on best practices for using adjunctive treatment for major depressive disorder. Optional CME/CE Credits and Certificate Instructions: After listening to the podcast, to take the optional posttest and receive CME/CE credit, click https://nei.global/POD21-MDD Learning Objectives: After …
 
What are some of the biggest changes that were made to the Fifth Edition and what were the reasons behind these changes? How are mood stabilizers redefined in the Fifth Edition? In this episode, Dr. Andrew Cutler interviews Dr. Stephen Stahl about all the updates to the Fifth Edition of Stahl’s Essential Psychopharmacology and all the exciting reas…
 
What is unique about collaborative care, when it comes to mental health? Can you share some of the step-by -step guide to implementing the core model in clinical practice for collaborative care? In this episode, Dr. Anna Ratzliff answers these questions and much more! Dr. Anna Ratzliff is a national expert on collaborative care and specifically, on…
 
In this episode, Dr. Andrew Cutler interviews Dr. Jonathan Meyer on best practices and strategies for improving clinician and patient communication, medication adherence, and collaboration in the community when it comes to treating schizophrenia. Optional CE Credits / Certificate Instructions: After listening to the podcast, to take the optional po…
 
What are the most critical components that need to be addressed about social wellbeing when it comes to children returning to school? What signs might alert parents to their children feeling anxious about returning to school? In this timely and important interview. Dr. Manpreet Singh and Dr. Jeffrey Strawn answer these questions and much more! To a…
 
What is the difference between mediators and moderators, and how do they influence treatment response? Why is it so important, as clinicians to understand the distinction between moderators and mediators and to be aware of their influence on treatment outcomes in the literature? In this episode, Dr. Andrew Cutler interviews Dr. Stephen Stahl and Dr…
 
Why is it so important that many Olympic athletes are speaking out about the importance of mental health, and how can people spread more awareness for mental health concerns in this vulnerable population? What challenges do you face regarding effectively treating mental health conditions in athletes? In this important and timely interview sports ps…
 
In this episode, Dr. Andrew Cutler interviews Dr. Leslie Citrome on some of the challenges that clinicians face when using traditional methods for the treatment of schizophrenia. They discuss the most current research on the development of TAAR1 agonists as a novel class of psychotropic medication for the treatment of schizophrenia. Optional CME Cr…
 
How do you handle a patient who doesn’t want to talk about their suicidal thoughts? What tools and basic education strategies can we use for non-health-care professionals to highlight and prevent potential suicide/suicidal thoughts? In this episode, Dr. Christine Moutier addressed your unanswered questions from the NEI Synapse Half Day: Before It’s…
 
How does the therapeutic alliance influence treatment outcomes when it comes to treatment with placebo? What are some of the other patient characteristics that influence placebo responsivity? In this episode, Dr. Andrew Cutler interviews Dr. Stephen Stahl and Dr. Joseph Goldberg about their recent book, Practical Psychopharmacology: Translating Fin…
 
What are the most common mistakes in psychopharmacology, where clinicians could benefit from improvement in these areas? What are some ways in which clinicians can avoid malpractice lawsuits? In this podcast episode, Dr. Thomas Schwartz discusses the biggest mistakes that can be made in psychopharmacology, as well as best practices for clinicians t…
 
What do we know about the world suicide rate and the national suicide rate? What are the differences and how might they be explained? How does the role of medications help or hinder suicide prevention? In this episode, Dr. Andrew Cutler interviews Dr. Christine Moutier and Dr. Stephen Stahl on their Suicide Prevention Handbook, where they address t…
 
What are the positive and negative consequences surrounding self-diagnosis programs for mental health? What can you say about the trend on TikTok to take L-tyrosine? It’s apparently been nicknamed the “natural Adderall”. What is wrong with this, or potentially dangerous about this? In this episode, Dr. Kojo Sarfo, discusses the positive and negativ…
 
What are the most frequent comorbidities of schizophrenia? Is there any scientific reason to use any antipsychotic in twice-a-day dosing? In this episode, Dr. Leslie Citrome addresses these questions and more of your unanswered questions from the NEI Synapse Half-Day on Novel Strategies to Treat Schizophrenia in this special NEI Podcast Bonus episo…
 
What unique risk factors surround the COVID-19 pandemic and potential heightened risk of suicide? What populations have been most vulnerable to mental health consequences, substance use disorders, suicidal ideation, and self-harm during the pandemic and why? In this episode, Dr. Andrew Cutler interviews Dr. Roger McIntyre and Dr. Stephen Stahl on t…
 
What are some mental health challenges for Asian Americans today? Can you share your thoughts on the most recent acts of violence against Asian Americans and where it comes from? In this timely and important episode, we interview Dr. Rona Hu on mental health in the Asian American community. Dr. Hu is Medical Director of the Acute Psychiatric Inpati…
 
What is the evidence that obesity leaves one vulnerable to bipolar disorder? Which of your patients with bipolar disorder would you refer for TMS and what has been the outcome in your experience? Have you seen development of mania with this treatment? What impact or changes have you seen in your bipolar patients who have suffered with COVID? In thi…
 
What do clinicians need to know about the pharmacokinetics of ketamine, especially when it comes to drug-drug interactions? What is the abuse potential for ketamine and for esketamine? What are some ways that clinicians can mitigate the risk of abuse? At this time, what is the consensus, in comparing the efficacy of ketamine and esketamine for trea…
 
What has the research shown in terms of the relationship between THC and sleep and nightmares in patients with PTSD? What are your thoughts on the recent study by LaFrance et al. that claimed that PTSD symptoms were reduced by more than 50% after cannabis use? In this fascinating interview with Dr. Kari Franson, we discuss the evidence for and agai…
 
What exactly is reconsolidation? How does disrupting this process work to neutralize fear conditioning? How has hallucinogen-assisted psychotherapy been implemented as an attempt to block reconsolidation of activated memories during psychotherapy sessions In this episode, as part of our special series, the PsychopharmaStahlogy Show, Dr. Andrew Cutl…
 
What are the risk factors for pediatric anxiety, and how might those be altered by the pandemic? How can emotional intelligence and emotion regulation play a role in managing anxiety? What is self-efficacy, and why is it so important for managing pediatric anxiety? In this timely episode, we discuss how to manage pediatric anxiety with Dr. Krystal …
 
What has research shown about the effectiveness of psychedelic or dissociative agents in the treatment of addiction? What is pharmacological extinction? What types of addictions have been researched, using this method as a treatment approach? In Part II of this special series, the PsychopharmaStahlogy Show Dr. Andrew Cutler asks Dr. Stephen Stahl t…
 
What are the greatest mental health disparities in this population? What has been particularly challenging for the transgender population during the COVID-19 pandemic? How can clinicians help recognize and treat the mental health needs of patients in the LGBTQ community, if they do not have advanced or specialized training for this population? In t…
 
What types of psychotherapies are typically used in conjunction with these dissociative agents? How does psilocybin differ from ketamine for the treatment of mental health conditions? What are the risks, if any associated with this type of therapeutic approach? In Part I of this special series, the PsychopharmaStahlogy Show Dr. Andrew Cutler asks D…
 
Loading …

Quick Reference Guide

Copyright 2022 | Sitemap | Privacy Policy | Terms of Service
Google login Twitter login Classic login